13
Views
16
CrossRef citations to date
0
Altmetric
Article

Transcriptional Link between Blood and Bone: the Stem Cell Leukemia Gene and Its +19 Stem Cell Enhancer Are Active in Bone Cells

, , , , , , , , , & show all
Pages 2615-2625 | Received 10 Sep 2005, Accepted 30 Dec 2005, Published online: 27 Mar 2023

REFERENCES

  • Akiyama, H., T. Kamitani, X. Yang, R. Kandyil, L. C. Bridgewater, M. Fellous, Y. Mori-Akiyama, and B. de Crombrugghe. 2005. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site. Matrix Biol. 23:499–505.
  • Bodine, P. V., M. Trailsmith, and B. S. Komm. 1996. Development and characterization of a conditionally transformed adult human osteoblastic cell line. J. Bone Miner. Res. 11:806–819.
  • Calvi, L. M., G. B. Adams, K. W. Weibrecht, J. M. Weber, D. P. Olson, M. C. Knight, R. P. Martin, E. Schipani, P. Divieti, F. R. Bringhurst, L. A. Milner, H. M. Kronenberg, and D. T. Scadden. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841–846.
  • Chen, C. Z., M. Li, D. de Graaf, S. Monti, B. Gottgens, M. J. Sanchez, E. S. Lander, T. R. Golub, A. R. Green, and H. F. Lodish. 2002. Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 99:15468–15473.
  • Choi, K., M. Kennedy, A. Kazarov, J. C. Papadimitriou, and G. Keller. 1998. A common precursor for hematopoietic and endothelial cells. Development 125:725–732.
  • Colnot, C., C. Lu, D. Hu, and J. A. Helms. 2004. Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev. Biol. 269:55–69.
  • Cumano, A., J. C. Ferraz, M. Klaine, J. P. Di Santo, and I. Godin. 2001. Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution. Immunity 15:477–485.
  • Dekel, B., E. Hochman, M. J. Sanchez, N. Maharshak, N. Amariglio, A. R. Green, and S. Izraeli. 2004. Kidney, blood, and endothelium: developmental expression of stem cell leukemia during nephrogenesis. Kidney Int. 65:1162–1169.
  • Dominici, M., C. Pritchard, J. E. Garlits, T. J. Hofmann, D. A. Persons, and E. M. Horwitz. 2004. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc. Natl. Acad. Sci. USA 101:11761–11766.
  • Ducy, P., R. Zhang, V. Geoffroy, A. L. Ridall, and G. Karsenty. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747–754.
  • Eames, B. F., L. de la Fuente, and J. A. Helms. 2003. Molecular ontogeny of the skeleton. Birth Defects Res. C 69:93–101.
  • Eguchi, M., M. Eguchi-Ishimae, A. Green, T. Enver, and M. Greaves. 2005. Directing oncogenic fusion genes into stem cells via an SCL enhancer. Proc. Natl. Acad. Sci. USA 102:1133–1138.
  • Ema, M., P. Faloon, W. J. Zhang, M. Hirashima, T. Reid, W. L. Stanford, S. Orkin, K. Choi, and J. Rossant. 2003. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev. 17:380–393.
  • Ferron, M., and J. Vacher. 2005. Targeted expression of Cre recombinase in macrophages and osteoclasts in transgenic mice. Genesis 41:138–145.
  • Gering, M., A. R. Rodaway, B. Gottgens, R. K. Patient, and A. R. Green. 1998. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J. 17:4029–4045.
  • Gothert, J. R., S. E. Gustin, M. A. Hall, A. R. Green, B. Gottgens, D. J. Izon, and C. G. Begley. 2005. In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood 105:2724–2732.
  • Gottgens, B., L. M. Barton, J. G. Gilbert, A. J. Bench, M. J. Sanchez, S. Bahn, S. Mistry, D. Grafham, A. McMurray, M. Vaudin, E. Amaya, D. R. Bentley, A. R. Green, and A. M. Sinclair. 2000. Analysis of vertebrate SCL loci identifies conserved enhancers. Nat. Biotechnol. 18:181–186.
  • Gottgens, B., C. Broccardo, M. J. Sanchez, S. Deveaux, G. Murphy, J. R. Gothert, E. Kotsopoulou, S. Kinston, L. Delaney, S. Piltz, L. M. Barton, K. Knezevic, W. N. Erber, C. G. Begley, J. Frampton, and A. R. Green. 2004. The SCL +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5′ bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1. Mol. Cell. Biol. 24:1870–1883.
  • Gottgens, B., F. McLaughlin, E. O. Bockamp, J. L. Fordham, C. G. Begley, K. Kosmopoulos, A. G. Elefanty, and A. R. Green. 1997. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements. Oncogene 15:2419–2428.
  • Gottgens, B., A. Nastos, S. Kinston, S. Piltz, E. C. Delabesse, M. Stanley, M. J. Sanchez, A. Ciau-Uitz, R. Patient, and A. R. Green. 2002. Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J. 21:3039–3050.
  • Hall, M. A., N. J. Slater, C. G. Begley, J. M. Salmon, L. J. Van Stekelenburg, M. P. McCormack, S. M. Jane, and D. J. Curtis. 2005. Functional but abnormal adult erythropoiesis in the absence of the stem cell leukemia gene. Mol. Cell. Biol. 25:6355–6362.
  • Hanaoka, H. 1979. The origin of the osteoclast. Clin. Orthop. Relat. Res. 145:252–263.
  • Huber, T. L., V. Kouskoff, H. J. Fehling, J. Palis, and G. Keller. 2004. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 432:625–630.
  • Kallianpur, A. R., J. E. Jordan, and S. J. Brandt. 1994. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83:1200–1208.
  • Karsenty, G., and E. F. Wagner. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2:389–406.
  • Kato, Y., J. J. Windle, B. A. Koop, G. R. Mundy, and L. F. Bonewald. 1997. Establishment of an osteocyte-like cell line, MLO-Y4. J. Bone Miner. Res. 12:2014–2023.
  • Kawaguchi, J., P. J. Mee, and A. G. Smith. 2005. Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone 36:758–769.
  • Kennedy, M., M. Firpo, K. Choi, C. Wall, S. Robertson, N. Kabrun, and G. Keller. 1997. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386:488–493.
  • Kiel, M. J., O. H. Yilmaz, T. Iwashita, C. Terhorst, and S. J. Morrison. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:1109–1121.
  • Lecuyer, E., and T. Hoang. 2004. SCL: from the origin of hematopoiesis to stem cells and leukemia. Exp. Hematol. 32:11–24.
  • Le Douarin, N., and C. Kalcheim. 1999. The neural crest, 2nd ed. Cambridge University Press, Cambridge, United Kingdom.
  • Lee, D. Y., J. J. Hayes, D. Pruss, and A. P. Wolffe. 1993. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72:73–84.
  • Matsuoka, T., P. E. Ahlberg, N. Kessaris, P. Iannarelli, U. Dennehy, W. D. Richardson, A. P. McMahon, and G. Koentges. 2005. Neural crest origins of the neck and shoulder. Nature 436:347–355.
  • Medvinsky, A., and E. Dzierzak. 1996. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86:897–906.
  • Murphy, G. J., B. Gottgens, A. Vegiopoulos, M. J. Sanchez, A. D. Leavitt, S. P. Watson, A. R. Green, and J. Frampton. 2003. Manipulation of mouse hematopoietic progenitors by specific retroviral infection. J. Biol. Chem. 278:43556–43563.
  • Olmsted-Davis, E. A., Z. Gugala, F. Camargo, F. H. Gannon, K. Jackson, K. A. Kienstra, H. D. Shine, R. W. Lindsey, K. K. Hirschi, M. A. Goodell, M. K. Brenner, and A. R. Davis. 2003. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc. Natl. Acad. Sci. USA 100:15877–15882.
  • Olsen, B. R., A. M. Reginato, and W. Wang. 2000. Bone development. Annu. Rev. Cell Dev. Biol. 16:191–220.
  • Phillips, B. W., N. Belmonte, C. Vernochet, G. Ailhaud, and C. Dani. 2001. Compactin enhances osteogenesis in murine embryonic stem cells. Biochem. Biophys. Res. Commun. 284:478–484.
  • Pulford, K., N. Lecointe, K. Leroy-Viard, M. Jones, D. Mathieu-Mahul, and D. Y. Mason. 1995. Expression of TAL-1 proteins in human tissues. Blood 85:675–684.
  • Rainis, L., T. Toki, J. E. Pimanda, E. Rosenthal, K. Machol, S. Strehl, B. Gottgens, E. Ito, and S. Izraeli. 2005. The proto-oncogene ERG in megakaryoblastic leukemias. Cancer Res. 65:7596–7602.
  • Raouf, A., and A. Seth. 2000. Ets transcription factors and targets in osteogenesis. Oncogene 19:6455–6463.
  • Robb, L., I. Lyons, R. Li, L. Hartley, F. Kontgen, R. P. Harvey, D. Metcalf, and C. G. Begley. 1995. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA 92:7075–7079.
  • Robertson, S. M., M. Kennedy, J. M. Shannon, and G. Keller. 2000. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development 127:2447–2459.
  • Robin, C., and E. Dzierzak. 2005. Hematopoietic stem cell enrichment from the AGM region of the mouse embryo. Methods Mol. Med. 105:257–272.
  • Sanchez, M., B. Gottgens, A. M. Sinclair, M. Stanley, C. G. Begley, S. Hunter, and A. R. Green. 1999. An SCL 3′ enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. Development 126:3891–3904.
  • Sanchez, M. J., E. O. Bockamp, J. Miller, L. Gambardella, and A. R. Green. 2001. Selective rescue of early haematopoietic progenitors in Scl(-/-) mice by expressing Scl under the control of a stem cell enhancer. Development 128:4815–4827.
  • Sato, M., E. Morii, T. Komori, H. Kawahata, M. Sugimoto, K. Terai, H. Shimizu, T. Yasui, H. Ogihara, N. Yasui, T. Ochi, Y. Kitamura, Y. Ito, and S. Nomura. 1998. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17:1517–1525.
  • Shalaby, F., J. Ho, W. L. Stanford, K. D. Fischer, A. C. Schuh, L. Schwartz, A. Bernstein, and J. Rossant. 1997. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:981–990.
  • Shivdasani, R. A., E. L. Mayer, and S. H. Orkin. 1995. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373:432–434.
  • Shubin, N., C. Tabin, and S. Carroll. 1997. Fossils, genes and the evolution of animal limbs. Nature 388:639–648.
  • Silberstein, L., M. J. Sanchez, M. Socolovsky, Y. Liu, G. Hoffman, S. Kinston, S. Piltz, M. Bowen, L. Gambardella, A. R. Green, and B. Gottgens. 2005. Transgenic analysis of the stem cell leukemia +19 stem cell enhancer in adult and embryonic hematopoietic and endothelial cells. Stem Cells. 23:1378–1388.
  • Sinclair, A. M., B. Gottgens, L. M. Barton, M. L. Stanley, L. Pardanaud, M. Klaine, M. Gering, S. Bahn, M. Sanchez, A. J. Bench, J. L. Fordham, E. Bockamp, and A. R. Green. 1999. Distinct 5′ SCL enhancers direct transcription to developing brain, spinal cord, and endothelium: neural expression is mediated by GATA factor binding sites. Dev. Biol. 209:128–142.
  • Suda, T., F. Arai, and A. Hirao. 2005. Hematopoietic stem cells and their niche. Trends Immunol. 26:426–433.
  • Tong, Q., G. Dalgin, H. Xu, C. N. Ting, J. M. Leiden, and G. S. Hotamisligil. 2000. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290:134–138.
  • Towler, D. A., and R. St. Arnaud. 2002. Use of cultured osteoblastic cells to identify and characterize transcriptional regulatory complexes, p. 1503–1527. In J. P. Bilezikian and G. A. Rodan (ed.), Principles of bone biology, 2nd ed. Academic Press, London, England.
  • Visvader, J. E., Y. Fujiwara, and S. H. Orkin. 1998. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12:473–479.
  • Wu, J., F. Iwata, J. A. Grass, C. S. Osborne, L. Elnitski, P. Fraser, O. Ohneda, M. Yamamoto, and E. H. Bresnick. 2005. Molecular determinants of NOTCH4 transcription in vascular endothelium. Mol. Cell. Biol. 25:1458–1474.
  • Yang, X., and G. Karsenty. 2002. Transcription factors in bone: developmental and pathological aspects. Trends Mol. Med. 8:340–345.
  • Zhang, J., C. Niu, L. Ye, H. Huang, X. He, W. G. Tong, J. Ross, J. Haug, T. Johnson, J. Q. Feng, S. Harris, L. M. Wiedemann, Y. Mishina, and L. Li. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836–841.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.